Detalles de la búsqueda
1.
Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial.
Lancet Oncol
; 17(11): 1543-1557, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27660192
2.
A candidate gene study of capecitabine-related toxicity in colorectal cancer identifies new toxicity variants at DPYD and a putative role for ENOSF1 rather than TYMS.
Gut
; 64(1): 111-20, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24647007
3.
Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial.
Lancet Oncol
; 15(8): 894-904, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24950987
4.
Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial.
Lancet Rheumatol
; 6(2): e92-e104, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38267107
5.
Effects of temporarily suspending low-dose methotrexate treatment for 2 weeks after SARS-CoV-2 vaccine booster on vaccine response in immunosuppressed adults with inflammatory conditions: protocol for a multicentre randomised controlled trial and nested mechanistic substudy (Vaccine Response On/Off Methotrexate (VROOM) study).
BMJ Open
; 12(5): e062599, 2022 05 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35504634
6.
Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial.
Lancet Respir Med
; 10(9): 840-850, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35772416
7.
Hormone replacement therapy (conjugated oestrogens plus bazedoxifene) for post-menopausal women with symptomatic hand osteoarthritis: primary report from the HOPE-e randomised, placebo-controlled, feasibility study.
Lancet Rheumatol
; 4(10): e725-e737, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36341025
8.
Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer.
N Engl J Med
; 357(4): 360-9, 2007 Jul 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-17652651
9.
Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis.
J Clin Oncol
; 32(10): 1031-9, 2014 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24590654
10.
Phase III randomized trial assessing rofecoxib in the adjuvant setting of colorectal cancer: final results of the VICTOR trial.
J Clin Oncol
; 28(30): 4575-80, 2010 Oct 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-20837956
Resultados
1 -
10
de 10
1
Próxima >
>>